
|Articles|March 19, 2017
Implications of Healthcare Reform Highlight AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
3
FDA Expands Accelerated Approval of Sevabertinib to First-Line HER2-Mutant NSCLC
4
Community Pharmacy Can Win and Still Lose
5






































































































